These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 27514515)

  • 1. Chronic viral hepatitis: policy, regulation, and strategies for its control and elimination in Ethiopia.
    Shiferaw F; Letebo M; Bane A
    BMC Public Health; 2016 Aug; 16(1):769. PubMed ID: 27514515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovative strategies for the elimination of viral hepatitis at a national level: A country case series.
    Schröeder SE; Pedrana A; Scott N; Wilson D; Kuschel C; Aufegger L; Atun R; Baptista-Leite R; Butsashvili M; El-Sayed M; Getahun A; Hamid S; Hammad R; 't Hoen E; Hutchinson SJ; Lazarus JV; Lesi O; Li W; Binti Mohamed R; Olafsson S; Peck R; Sohn AH; Sonderup M; Spearman CW; Swan T; Thursz M; Walker T; Hellard M; Howell J
    Liver Int; 2019 Oct; 39(10):1818-1836. PubMed ID: 31433902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adapting HIV patient and program monitoring tools for chronic non-communicable diseases in Ethiopia.
    Letebo M; Shiferaw F
    Global Health; 2016 Jun; 12(1):26. PubMed ID: 27255329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Informing the design of a national screening and treatment programme for chronic viral hepatitis in primary care: qualitative study of at-risk immigrant communities and healthcare professionals.
    Sweeney L; Owiti JA; Beharry A; Bhui K; Gomes J; Foster GR; Greenhalgh T
    BMC Health Serv Res; 2015 Mar; 15():97. PubMed ID: 25890125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of Kenya's cancer policies to improve access to cancer testing and treatment in the country.
    Makau-Barasa LK; Greene S; Othieno-Abinya NA; Wheeler SB; Skinner A; Bennett AV
    Health Res Policy Syst; 2020 Jan; 18(1):2. PubMed ID: 31910868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience of living with multimorbidity and health workers perspectives on the organization of health services for people living with multiple chronic conditions in Bahir Dar, northwest Ethiopia: a qualitative study.
    Eyowas FA; Schneider M; Alemu S; Getahun FA
    BMC Health Serv Res; 2023 Mar; 23(1):232. PubMed ID: 36890489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference.
    Papatheodoridis G; Thomas HC; Golna C; Bernardi M; Carballo M; Cornberg M; Dalekos G; Degertekin B; Dourakis S; Flisiak R; Goldberg D; Gore C; Goulis I; Hadziyannis S; Kalamitsis G; Kanavos P; Kautz A; Koskinas I; Leite BR; Malliori M; Manolakopoulos S; Matičič M; Papaevangelou V; Pirona A; Prati D; Raptopoulou-Gigi M; Reic T; Robaeys G; Schatz E; Souliotis K; Tountas Y; Wiktor S; Wilson D; Yfantopoulos J; Hatzakis A
    J Viral Hepat; 2016 Feb; 23 Suppl 1():1-12. PubMed ID: 26809941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers for tuberculosis case finding in Southwest Ethiopia: A qualitative study.
    Ereso BM; Yimer SA; Gradmann C; Sagbakken M
    PLoS One; 2020; 15(1):e0226307. PubMed ID: 31895932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Language support for linguistic minority chronic hepatitis B/C patients: an exploratory study of availability and clinicians' perceptions of language barriers in six European countries.
    Falla AM; Veldhuijzen IK; Ahmad AA; Levi M; Richardus JH
    BMC Health Serv Res; 2017 Feb; 17(1):150. PubMed ID: 28219385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress on the elimination of viral hepatitis in Zimbabwe: A review of the policies, strategies and challenges.
    Dzingirai B; Katsidzira L; Matyanga CMJ; Postma MJ; van Hulst M; Mafirakureva N
    J Viral Hepat; 2021 Jul; 28(7):994-1002. PubMed ID: 33797190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers and Strategies for Hepatitis B and C Elimination in Pakistan.
    Qureshi H; Mahmood H; Sabry A; Hermez J
    J Infect Dis; 2023 Sep; 228(Suppl 3):S204-S210. PubMed ID: 37703344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The State of Hepatitis C Elimination from the Front Lines: A Qualitative Study of Provider-Perceived Gaps to Treatment Initiation.
    Gonzalez CJ; Kapadia SN; Niederdeppe J; Dharia A; Talal AH; Lloyd AR; Franco R; Labossiere S; Shapiro MF; Wethington E
    J Gen Intern Med; 2024 Sep; 39(12):2268-2276. PubMed ID: 38782810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating private health facilities in government-led health systems: a case study of the public-private mix approach in Ethiopia.
    Ali D; Woldegiorgis AG; Tilaye M; Yilma Y; Berhane HY; Tewahido D; Abelti G; Neill R; Silla N; Gilliss L; Mandal M
    BMC Health Serv Res; 2022 Dec; 22(1):1477. PubMed ID: 36463163
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.